Business
Press Release Feb 24 2023
Strides Pharma Science Limited has informed the Exchange regarding a press release dated February 24, 2023, titled "Strides flagship facility in Bangalore receives USFDA inspection closure".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated February 24, 2023, titled "Strides flagship facility in Bangalore receives USFDA inspection closure". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd